Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 4 OF 72 | DISPLAYING 46 - 60 OF 1069 RESULTS

    Lou E et al., Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study., , Oncologist, Jul 25, 2019

    Seban R et al., Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics., , Eur J Nucl Med Mol Imaging., Jul 23, 2019

    Johnson DB et al., A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis., , Nat Med., Jul 22, 2019

    McGray AJR et al., Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer, , J Immunother Cancer, Jul 17, 2019

    McIntyre JB et al., MYB-NFIB gene fusions identified in archival adenoid cystic carcinoma tissue employing NanoString analysis: an exploratory study., , Diagn Pathol., Jul 13, 2019

    Wirsching HG et al., Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma., , JCI Insight., Jul 11, 2019

    Stackhouse CT et al., A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening, , Cells, Jul 11, 2019

    Harrington K et al., Optimizing oncolytic virotherapy in cancer treatment., , Nat Rev Drug Discov., Jul 10, 2019

    Salter dm et al., Development of mouse models of angiosarcoma driven by p53, , Dis Model Mech. , Jul 09, 2019

    Yang PS et al., A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer., , Jpn J Clin Oncol., Jul 09, 2019

    Chen X et al., Identifying and targeting angiogenesis-related microRNAs in ovarian cancer., , Oncogene, Jul 09, 2019

    Sin-Chan P et al., A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor, , Cancer Cell, Jul 08, 2019

    Pararajalingam P et al., Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing, , bioRxiv, Jul 08, 2019

    Tien AC et al., A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort., , Clin Cancer Res, Jul 08, 2019

    Heo YJ et al., Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue , , Sci Rep, Jul 04, 2019